Paper41390489
Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation.
Sfakianos AP and 22 others. Nat Commun, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation. Papers, record 41390489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41390489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Peptide Initiation Factors | Major topic |
| RNA-Binding Proteins | Major topic |
| Peptide Chain Elongation, Translational | Major topic |
| Neoplasms | Major topic |
| Peptide Chain Initiation, Translational | Major topic |
| Eukaryotic Translation Initiation Factor 5A | |
| Humans | |
| Cell Proliferation | |
| Phosphorylation | |
| Cell Line, Tumor | |
| Eukaryotic Initiation Factor-2 | |
| Feedback, Physiological | |
| Protein Biosynthesis | |
| Signal Transduction | |
| Mitochondria |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| A24388 | Cancer Research UK (CRUK) | PubMed | ||
| MC_UP_A600_1023 | RCUK | Medical Research Council (MRC) | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39743589 | Aspartate signalling drives lung metastasis via alternative translation. | Nature | 2025 | https://conductscience.org/library/papers/39743589 | PubMed |
| 2 | 18954100 | Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC. | J Proteome Res | 2009 | https://conductscience.org/library/papers/18954100 | PubMed |
| 3 | 20181941 | The role of polyamines in supporting growth of mammalian cells is mediated through their requirement for translation initiation and elongation. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20181941 | PubMed |
| 4 | 31801078 | Suppression of Ribosomal Pausing by eIF5A Is Necessary to Maintain the Fidelity of Start Codon Selection. | Cell Rep | 2019 | https://conductscience.org/library/papers/31801078 | PubMed |
| 5 | 32375038 | Genome-wide Survey of Ribosome Collision. | Cell Rep | 2020 | https://conductscience.org/library/papers/32375038 | PubMed |
| 6 | 28549188 | eIF5A facilitates translation termination globally and promotes the elongation of many non polyproline-specific tripeptide sequences. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28549188 | PubMed |
| 7 | 6403941 | Identification of the hypusine-containing protein hy+ as translation initiation factor eIF-4D. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6403941 | PubMed |
| 8 | 32298235 | Control of translation elongation in health and disease. | Dis Model Mech | 2020 | https://conductscience.org/library/papers/32298235 | PubMed |
| 9 | 25218134 | The spermidine analogue GC7 (N1-guanyl-1,7-diamineoheptane) induces autophagy through a mechanism not involving the hypusination of eIF5A. | Amino Acids | 2014 | https://conductscience.org/library/papers/25218134 | PubMed |
| 10 | 33852845 | eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction. | Cell Rep | 2021 | https://conductscience.org/library/papers/33852845 | PubMed |
| 11 | 34900714 | Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven Tumors. | Front Oncol | 2021 | https://conductscience.org/library/papers/34900714 | PubMed |
| 12 | 37327776 | A mitochondrial iron-responsive pathway regulated by DELE1. | Mol Cell | 2023 | https://conductscience.org/library/papers/37327776 | PubMed |
| 13 | 29036434 | Novel mechanisms of eIF2B action and regulation by eIF2α phosphorylation. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/29036434 | PubMed |
| 14 | 35388015 | DELE1 tracks perturbed protein import and processing in human mitochondria. | Nat Commun | 2022 | https://conductscience.org/library/papers/35388015 | PubMed |
| 15 | 36915194 | Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/36915194 | PubMed |
| 16 | 7023881 | A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. | Cytometry | 1980 | https://conductscience.org/library/papers/7023881 | PubMed |
| 17 | 35487398 | Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35487398 | PubMed |
| 18 | 14622290 | Identification and characterization of eukaryotic initiation factor 5A-2. | Eur J Biochem | 2003 | https://conductscience.org/library/papers/14622290 | PubMed |
| 19 | 27746856 | Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27746856 | PubMed |
| 20 | 23764021 | Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23764021 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42709785 | eIF5A and polyamines restrict mRNA levels in response to ribosome stalls. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42709785 | PubMed |
| 42620389 | Dual relevance of EIF2S1 in acute myeloid leukemia: linking poor prognosis to immune-metabolic states and leukemic cell fitness. | Front Oncol | 2026 | https://conductscience.org/library/papers/42620389 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41390489
GET https://conductscience.org/api/papers/v1/41390489/authors?page=2